Intersection of Innovative Development Models and Investment Approaches That Move the Needle at the Portfolio Level
New to SCOPE 2024 - we bring together for the first time, a business-focused panel of strategics from the pharma, investor, healthcare, CRO, and technology start-up communities, to discuss partnership models that drive much needed innovation in clinical trials and impact development at the portfolio level. In this panel we will address the following questions:
- How can Pharma manage risks and investments while continuing to remain at the forefront of drug development, clinical research, and trial technology?
- What alternative business models and risk-sharing partnership can support innovation, in a resource constrained environment?
- Where are the opportunities and the ROI from such partnerships?
- What emerging technologies are showing growth and investment and are moving the needle in clinical research?